About this trial
The current role of the rotational atherectomy is for non-dilatable coronary lesions and for severely calcified lesions that may interfere with optimal stent expansion.
Severely calcified coronary lesions are associated with worse outcomes. In this regard, chronic kidney disease is associated with severely calcified coronary arteries.
Some evidence suggests that elective rotational atherectomy used by experienced operators can be safe and effective, minimizing time and complications for patients with heavily calcified lesions.
However, there is no direct randomized comparison between rotational atherectomy and angioplasty alone in the setting of chronic renal failure and with intravascular ultrasound assessment for detecting severely calcified coronary arteries.
Eligibility criteria
Qualifiers
Patients >18 years.
Glomerular filtration rate (GFR) <60 mL/min/1.73 m2 for 3 months or more
Stenosis ≥70% in a coronary artery with a diameter ≥2,5 mm.
Severe angiographic calcification (affecting both sides of the arterial lumen)
Disqualifiers
Absence of informed consent.
Acute myocardial infarction in the first 7 days of evolution.
Lesion in a single patent vessel.
Calcified lesions with an angulation >60º, dissections, lesions with thrombus, and degenerated saphenous vein grafts.
Trial design
Treatments tested in this trial
- Percutaneous coronary intervention (PCI)
Treatment groups
Sponsors and collaborators
Guillermo Galeote; MD, PhD
Lead sponsor
Hospital Universitario La Paz
Sponsor institution